Richard S Sackler

USPTO Granted Patents = 48 (Patent Applications = 11)

CIPO Patents = 2

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 1.9

ph-index = 26

Forward Citations = 3,861(Granted Patents)

Company Filing History:

Rhodes Pharmaceuticals L.p.

patents

Years Active: 1984-2018

Loading Chart...

48 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10028947 - Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent (2018-07-24),

2. 10022369 - Pharmaceutical formulation containing irritant (2018-07-17),

3. 9895317 - Tamper resistant solid oral dosage forms (2018-02-20),

4. 9861628 - Buprenorphine-wafer for drug substitution therapy (2018-01-09),

5. 9763931 - Buprenorphine-wafer for drug substitution therapy (2017-09-19),

6. 9737529 - Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent (2017-08-22),

7. 9707180 - Methods of preparing tamper resistant solid oral dosage forms (2017-07-18),

8. 9511065 - Pharmaceutical formulation containing irritant (2016-12-06),

9. 9370512 - Buprenorphine-wafer for drug substitution therapy (2016-06-21),

10. 9326954 - Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent (2016-05-03),

11. 9233073 - Tamper resistant solid oral dosage forms (2016-01-12),

12. 9155717 - Pharmaceutical formulation containing irritant (2015-10-13),

13. 9101625 - Buprenorphine-wafer for drug substitution therapy (2015-08-11),

14. 8685994 - Analgesic combination of oxycodone and celecoxib (2014-04-01),

15. 8652515 - Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent (2014-02-18),

Title: Richard S. Sackler: Innovator in Pharmaceutical Formulations

Introduction: Richard S. Sackler, based in Greenwich, CT, is a prominent figure in the pharmaceutical industry, known for his significant contributions through his inventions. With a remarkable portfolio of 48 patents to his name, Sackler has dedicated his career to addressing the challenges associated with opioid medications and abuse.

Latest Patents: Among his latest innovations are two notable patents focusing on pharmaceutical formulations. The first patent describes a formulation containing an opioid agonist, an opioid antagonist, and an irritant agent. This oral dosage form is designed to deliver a therapeutically effective amount of an opioid analgesic while introducing an irritant that creates an unpleasant sensation if tampered with, thereby deterring abuse. The second patent elaborates on a similar concept, outlining a formulation that includes a drug susceptible to abuse paired with an irritant, again aimed at safeguarding against misuse.

Career Highlights: Richard Sackler's career has been marked by his involvement with leading companies in the pharmaceutical sector, including Purdue Pharma L.P. and Euro-Celtique S.A. His innovative work has contributed to the development of safer pharmaceutical products, positioning him as a valuable inventor in the industry.

Collaborations: Throughout his career, Sackler has worked alongside notable professionals such as Paul D. Goldenheim and Ronald M. Burch. These collaborations have further enriched his expertise and bolstered the impact of his inventions.

Conclusion: Richard S. Sackler's dedication to innovation in pharmaceutical formulations reflects his commitment to addressing critical public health issues. By leveraging his extensive experience and patent portfolio, he continues to pave the way for safer medication use and contribute to the evolving landscape of the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.